Bottom line: Pep is the simple choice for reminders and a routine dashboard, without the side-effect or medication-level depth of an all-in-one tracker
Phase 3 TRIUMPH trial results The Phase 3 TRIUMPH-4 trial, announced in late 2025, confirmed and even improved on the Phase 2 numbers
Acute hyperammonemia dialysis suggested (this is a bit fuzzy and requires some clinical judgement, since mild hyperammonemia can occur with mild-moderate valproate intoxication)
Starting with lower GLP-1 doses and gradually adapting to the ketogenic diet may improve tolerance
Continuous follow-up appointments are essential to monitor progress, address any side effects, and make necessary adjustments to the treatment plan
A similar study by Ramakrishna reported that glutathione was generated in radish to resist oxidative damage induced by zinc ions [29]